Research suggests a potential means of circumventing drug resistance in breast cancer

[News]

Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from The University of Texas M. D. Anderson Cancer Center report in Clinical Cancer Research.

More... (http://www.news-medical.net/news/20100210/Research-suggests-a-potential-means-of-circumventing-drug-resistance-in-breast-cancer-patients.aspx)